These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 7794024)

  • 41. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M; Simoncini T; Fuller S; Genazzani AR
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Receptivity to the sex steroids, physiopathological aspects].
    Bercovici JP
    Contracept Fertil Sex (Paris); 1984 Jun; 12(6):821-7. PubMed ID: 12313177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects on the breast of drugs used in fertility regulation.
    Mauvais-Jarvis P
    Hum Reprod; 1987 Feb; 2(2):159-62. PubMed ID: 3473070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of combined oral contraceptives on breast epithelial proliferation in young women.
    Garcia y Narvaiza D; Navarrete MA; Falzoni R; Maier CM; Nazário AC
    Breast J; 2008; 14(5):450-5. PubMed ID: 18657146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Links between hormone replacement therapy and neoplasia.
    Hulka BS
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
    Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
    Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estradiol 17 beta-hydroxysteroid dehydrogenase activity in human breast fibroadenomas.
    Fournier S; Kuttenn F; de Cicco F; Baudot N; Malet C; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1982 Sep; 55(3):428-33. PubMed ID: 6954155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause? Experimental vs. clinical data.
    Seeger H; Mueck AO
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):11-5. PubMed ID: 18206365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy.
    Jacobson HI; Lemanski N; Agarwal A; Narendran A; Turner KE; Bennett JA; Andersen TT
    Cancer Prev Res (Phila); 2010 Feb; 3(2):212-20. PubMed ID: 19934340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antiestrogen action of progesterone in the breast].
    Mauvais-Jarvis P; Kuttenn F; Gompel A; Benotmane A
    Pathol Biol (Paris); 1987 Sep; 35(7):1081-6. PubMed ID: 3313217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception.
    Africander D; Verhoog N; Hapgood JP
    Steroids; 2011 Jun; 76(7):636-52. PubMed ID: 21414337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of progestins and menstrual cycle on fatty acid synthetase and progesterone receptor in human mammary glands.
    Joyeux C; Chalbos D; Rochefort H
    J Clin Endocrinol Metab; 1990 May; 70(5):1438-44. PubMed ID: 2335579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Estradiol-progesterone interaction in normal and pathological human breast cells].
    Mauvais-Jarvis P; Kuttenn F; Gompel A; Malet C; Fournier S
    Ann Endocrinol (Paris); 1986; 47(3):179-87. PubMed ID: 3535636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estradiol/progesterone interaction in normal and pathologic breast cells.
    Mauvais-Jarvis P; Kuttenn F; Gompel A
    Ann N Y Acad Sci; 1986; 464():152-67. PubMed ID: 3524347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure of progestins to induce estradiol dehydrogenase activity in endometrial carcinoma, in vitro.
    Satyaswaroop PG; Mortel R
    Cancer Res; 1982 Apr; 42(4):1322-5. PubMed ID: 6949638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis.
    Asi N; Mohammed K; Haydour Q; Gionfriddo MR; Vargas OL; Prokop LJ; Faubion SS; Murad MH
    Syst Rev; 2016 Jul; 5(1):121. PubMed ID: 27456847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The estrogenic activity of synthetic progestins used in oral contraceptives.
    Jordan VC; Jeng MH; Catherino WH; Parker CJ
    Cancer; 1993 Feb; 71(4 Suppl):1501-5. PubMed ID: 8431886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.